期刊文献+

1126例病人血浆D-二聚体检测结果分析及临床应用 被引量:4

Results analysis of 1126 patients' D-Dimer in plasma and its clinical application
下载PDF
导出
摘要 目的探讨定量检测血浆D-二聚体(DD)在弥散性血管内凝血(DIC)及静脉栓塞疾病(VTE)诊断中的临床价值。方法使用sysmexCA7000全自动凝血仪采用免疫比浊法对1126例来自不同科室的住院可疑病人和66例健康体检者进行血浆D-二聚体定量检测并统计分析。结果不同科室收治的可疑病人根据其病情D-二聚体水平升高的阳性率不同,其检测值与健康组之间比较均有不同的差异(P<0.05)。ICU组:阳性率81%,检测值(851.8±206.6)ng/ml;普外科组:阳性率62%,检测值(433.6±131.4)ng/ml;呼吸内科:阳性率49%,检测值(279.1±92.3)ng/ml;血液内科:阳性率51%,检测值(341.7±102.5)ng/ml;急诊科:阳性率40%,检测值(258.9±91.7)ng/ml。其检测值与健康正常人相比差异有显著统计学意义(P<0.05)。结论 D-二聚体的检测对于临床评价DIC,VTE疾病具有重要的意义。 Objective: To determine quantitative detection of plasma D-Dimer and its clinical significance in DIC,VTE.Methods: D-Dimer of 1126 suspicious patients from different Departments and 66 healthy adults were quantitatively analyzed by immunity-turbidity method with Sysmex CA-7000 full-Automatic Coagulation Analyzer.Results: Different hospital departments received different suspicious patients.According to the patients' disease,the positive rate of the rise D-dimer levels was different.There was a difference between the patients' test value and the healthy persons'(P〈0.05).①Intensive Care Unit: The positive rate was 81%.The test value was(851.8±206.6)ng/ml;② Normal Surgical Department: The positive rate was 62%.The test value was(433.6±131.4)ng/ml;③ Respiratory Diseases Department: The positive rate was 49%.The test value was(279.1±92.3)ng/ml;④ Hematological Department: The positive rate was 51%.The test value was(341.7±102.5ng/ml;⑤ Emergency Department: The positive rate was 40%.The test value was(258.9± 91.7)ng/ml.The difference in D-dimer test value was also significant between the patients and the healthy persons(P〈0.05).Conclusion:The evaluation of the DIC and VTE disease has important significance in testing the plasma D-dimer level.It is closely related to the clinical medicine,which provides accurate and reliable bases for the clinical evaluation.
出处 《泰山医学院学报》 CAS 2011年第11期844-846,共3页 Journal of Taishan Medical College
关键词 D-二聚体 DIC VTE 临床应用 D-dimer test DIC VTE clinical application
  • 相关文献

参考文献7

二级参考文献37

  • 1Bergqvist D. Low molecular weight heparins[J].J Intern Med ,1996,240(1):63-72.
  • 2冈村孝.DIC(播种性血管内凝固症候群)[J].临床と研究,1997,74(8):77-81.
  • 3樱川信男 长谷川淳 真木正博ほか.汎发性血管内凝血症候群(DIC)に对する低分子ヘパリン(FR—860)の临床评价[J].临床医药,1992,8(3):423-452.
  • 4冈嵨研二.DIC.血栓症の治疗[M].ソデイ力ルレゼュ社,1996.321-334.
  • 5Ok ajima K, Uchiba M, Kaiji M et al.Nafamostat mesilate[J].Cardiovasc Drugs Rev,1995,13(1):51-65.
  • 6森美贵 和田英夫 小林透.抗Χa药[J].新药と临床,1999,35(1):69-74.
  • 7冈嵨研二.血管内皮细胞障害とDIC[J].临床血液,1998,40(5):373-377.
  • 8青木延雄.汎发性血管内血液凝固症候群(DIC)に对する干燥浓缩人活性化プロテインC制剂(CTC—Ⅲ)の临床试验—第Ⅲ相临床试验[J].新药と临床,1995,47(1):88-94.
  • 9Mohri M,Gonda Y,Oka Y et al.The antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM)on tissue factor -induced disseminated intravascular coagulation in crab-eating monkeys [J].Blood Coagulation and Fibrinolysis,1997,8(2):274-288.
  • 10Yokota Y,Inamura N,Asano M et al.Effects of FR128998,a novel PAF-receptor antagonist,on endotoxin-induced disseminated intravascular coagulation[J].Eur J Pharmacol,1994,258(2):239-246.

共引文献99

同被引文献16

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部